Inari Medical to Present at Upcoming Investor Conferences

Rhea-AI Summary

Inari Medical, Inc. (NASDAQ: NARI), a medical device company dedicated to treating venous diseases, announced its participation in two investor conferences. The 2021 Virtual Wells Fargo Healthcare Conference is set for September 9, 2021, at 4:00 p.m. ET, followed by the Morgan Stanley 19th Annual Global Healthcare Conference on September 13, 2021, at 1:15 p.m. ET. A live webcast of both presentations will be available on the company’s website. Inari Medical specializes in innovative catheter-based devices for treating deep vein thrombosis and pulmonary embolism.

IRVINE, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today that its management team will present at the following upcoming investor conferences:

• The 2021 Virtual Wells Fargo Healthcare Conference, Thursday, September 9, 2021 at 4:00 p.m. Eastern Time.
  
  
• The Morgan Stanley 19^th Annual Global Healthcare Conference, Monday, September 13, 2021 at 1:15 p.m. Eastern Time.
  

A live webcast and replay of the presentations may be accessed on the “Investor Relations” section of the company’s website at: https://www.inarimedical.com/.

About Inari Medical, Inc.
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium.

Investor Contact:
Westwicke Partners
Caroline Corner
Phone +1-415-202-5678
caroline.corner@westwicke.com

FAQ

What investor conferences is Inari Medical attending in September 2021?

Inari Medical will present at the 2021 Virtual Wells Fargo Healthcare Conference on September 9, 2021, and the Morgan Stanley 19th Annual Global Healthcare Conference on September 13, 2021.

What time will Inari Medical present at the Wells Fargo Healthcare Conference?

Inari Medical's presentation at the Wells Fargo Healthcare Conference will take place at 4:00 p.m. Eastern Time on September 9, 2021.

When is the Morgan Stanley Healthcare Conference presentation by Inari Medical?

Inari Medical's presentation at the Morgan Stanley Healthcare Conference is scheduled for September 13, 2021, at 1:15 p.m. Eastern Time.

Where can I watch Inari Medical's conference presentations?

You can watch the live webcast and replay of Inari Medical's conference presentations on the Investor Relations section of their website.

What medical conditions do Inari Medical's devices target?

Inari Medical focuses on treating venous diseases, specifically deep vein thrombosis and pulmonary embolism, with its catheter-based devices.